Number of patients, male	11
Number of patients, female	8
Stage	IV
Age	Median (range): 68 (45–85) years
Number of Prior Systemic Therapies	Median (range): 3 (1–5)
Performance Status: ECOG	0 — 7 1 — 12 2 — 0 3 — 0 Unknown — 0
Total Number of Patients	n = 19
Race	White: 16 (84%) Black or African American: 1 (5%) Asian: 2 (11%)
Prior Lines of Therapy	Median: 3 1: 3 (16%) 2: 6 (32%) ≥3: 10 (53%)
Prior Therapies	FOLFIRINOX: 14 (74%) Gemcitabine‐based regimen: 18 (95%)
BRCA 1/2 Mutation Status	Known or suspected germline BRCA mutation: 0 Unknown: 19